Cardiac rhabdomyoma in familial tuberous sclerosis

Amit Kumar Chaurasia1, S Harikrishnan, S Bijulal

  • 1Department of Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum 695 011, India.

Insights

Cardiac rhabdomyomas, often linked to tuberous sclerosis complex, are rare in infants. This case highlights a child with a right ventricular rhabdomyoma and tuberous sclerosis, where surgery was unnecessary due to the absence of heart failure symptoms.

Area of Science:

  • Pediatric Cardiology
  • Oncology
  • Genetics

Background:

  • Cardiac rhabdomyomas are benign tumors of the heart, frequently diagnosed in infants.
  • Tuberous sclerosis complex (TSC) is a genetic disorder with a high association with cardiac rhabdomyomas.

Observation:

  • A 5-month-old infant presented with a cardiac tumor in the right ventricle.
  • Echocardiography confirmed features consistent with a rhabdomyoma.
  • The infant and her father exhibited cutaneous manifestations indicative of tuberous sclerosis.

Findings:

  • The presence of a cardiac rhabdomyoma was confirmed in an infant with clinical signs of tuberous sclerosis.
  • The diagnosis was supported by echocardiographic findings and family history.

Implications:

  • Surgical intervention for cardiac rhabdomyomas is often not required, particularly in asymptomatic cases.
  • Management should focus on monitoring for potential complications like congestive heart failure.
  • Early recognition of tuberous sclerosis markers can aid in diagnosis and management of associated cardiac conditions.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K